Search

Your search keyword '"Lindgren, Peter"' showing total 1,112 results
Start Over Author "Lindgren, Peter"
1,112 results on '"Lindgren, Peter"'

2. Network Based High Speed Product Development

Author

Lindgren, Peter

Subjects
Production and quality control management, Information technology industries, bic Book Industry Communication::K Economics, finance, business & management::KJ Business & management::KJM Management & management techniques::KJMV Management of specific areas::KJMV5 Production & quality control management, bic Book Industry Communication::K Economics, finance, business & management::KN Industry & industrial studies::KNT Media, information & communication industries::KNTX Information technology industries
Abstract

In the first decade of the 21st century product development in networks was predicted to be of ever-increasing importance to businesses of all sizes because of changes in markets, in technology, in networks, and in the competences of Businesses. The growth in new products’ share of businesses’ total turnover and earnings were increasing at an unprecedented speed. The entrepreneurial innovations and technological improvements had resulted in the increasingly fast development of new products and services. Businesses and industries in different countries became increasingly more linked and interdependent in networks with respect to materials, business operations and particularly product development to match the wants and needs of the global market environment to high speed product development. Businesses were therefore encountering increasingly dynamic market fragmentation, shrinking time in market, increasing product variety, demands of production to customer specifications, reduced product lifetimes, and globalization of production.Networks were vital because the competition is not business against business, but network against network. Networks are vital because an increasing part of product development was carried out in all types of networks containing physical, ICT, dynamic, and virtual networks. Speed and pressure on time in product development seemed to continue to increase because customer demands for new products seemed to continue to increase. However, a Business seldom possessed all needed competences, and managers saw product development based on networks as an important solution to meet the strong competition of the future global markets and the strong demand for innovation and innovativeness. The evolution of market demands and focus (required) on competencies of businesses could be characterized as a development from a focus on efficiency, to a focus on quality and flexibility, to a focus on speed and innovativeness.This was why it was interesting and important to research and discuss product development and especially to understand high speed product development of individualized products in fragile market segments. Consequently, findings and learning on aspects like enablers, management tools, technological tools, product development models, product development processes and network tools to speed new product development are presented in this book.

Published
2017
Full Text
View/download PDF

3. Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators

Author

Solmi, Marco, Croatto, Giovanni, Gupta, Arnav, Fabiano, Nicholas, Wong, Stanley, Fornaro, Michele, Schneider, Lynne Kolton, Rohani-Montez, S. Christy, Fairley, Leanne, Smith, Nathalie, Bitter, István, Gorwood, Philip, Taipale, Heidi, Tiihonen, Jari, Cortese, Samuele, Dragioti, Elena, Rietz, Ebba Du, Nielsen, Rene Ernst, Firth, Joseph, Fusar-Poli, Paolo, Hartman, Catharina, Holt, Richard I G, Høye, Anne, Koyanagi, Ai, Larsson, Henrik, Lehto, Kelli, Lindgren, Peter, Manchia, Mirko, Nordentoft, Merete, Skonieczna-Żydecka, Karolina, Stubbs, Brendon, Vancampfort, Davy, De Prisco, Michele, Boyer, Laurent, Vieta, Eduard, and Correll, Christoph U.

Published
2024
Full Text
View/download PDF

4. Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe

Author

Van Poppel, Hendrik, Collen, Sarah, N’Dow, James, Cornford, Phillip, Gómez Rivas, Juan, Roobol-Bouts, Monique, Beyer, Katharina, Venderbos, Lionne, Helleman, Jozien, Leenen, Renée, Nieboer, Daan, Mulder, Esmée, Lodder, Jeroen, Denijs, Frederique, van den Bergh, Roderick, Talala, Kirsi, Kirkegaard, Pia, Andersen, Berit, Larsen, Mette Bach, Andersen, Sofie Meyer, McKinney, Grace, Hejduk, Karel, Májek, Ondřej, Ngo, Ondřej, Vyskot, Tomáš, Koudelková, Marcela, Zachoval, Roman, Chloupkova, Renata, Hejcmanova, Katerina, van Harten, Meike, Willemse, Peter-Paul, Couespel, Norbert, Moschetti, Riccardo, Morrissey, Mike, Price, Richard, Venegoni, Enea, Konusevska, Agnese, Colceriu, Otilia, Parker, Zoë, Dudek-Godeau, Dorota, Krynicka, Malgorzata, Tupikowski, Krzysztof, Hodyra-Stefaniak, Katarzyna, Litwin, Monika, Pajewska, Monika, Czerw, Aleksandra, Deptała, Andrzej, Amorín, Ángel Gómez, Luque, Silvia Suárez, Parrondo, Carmen Durán, Antelo, Ana Marina Tarrazo, Quinteiro, Montserrat Corujo, Vilaseca, Josep, Borrós, Gemma Cuberas, Bartés, Anna Arnau, Salazar, Juan Pablo, Llauradó, Hector López, Bratt, Ola, Godtman, Rebecka, Järbur, Emil, Jiborn, Thomas, Bjartell, Anders, Holst, Anna, Alterbeck, Max, Patašius, Aušvydas, Miksiene, Gintare, Smailytė, Giedrė, Mickeviciute, Ugne, Annemans, Lieven, Hutsebaut, Pieter-Jan, Vynckier, Pieter, Kidd, Robert, O’Brien, Michael, Keon, Paula, Lynch, Carolyne, Rooney, Michael, Kivi, Martin, Galvin, David, Rogers, Eamonn, Nolan, Eileen, Sweeney, Paul, Horgan, Gillian, Frese, Thomas, Denny, Kathleen, Bennett, Cate, O’Connor, Amy, Coghlan, Sarah, Le Roux, Ricky, Robb, Karen, Basu, Partha, Chandran, Arunah, Carvalho, Andre, Singh, Deependra, Palaniraja, Sathishrajaa, Otero-García, Milagros, Briers, Erik, Lantz, Anna, Eneqvist, Lisa Jelf, Raes, Sarah, Amrouch, Cheïma, Lindgren, Peter, Leenen, Renée C.A., Venderbos, Lionne D.F., van Harten, Meike J., Chloupková, Renata, Vasilyeva, Vera, Rivas, Juan Gomez, van den Bergh, Roderick C.N., Van Poppel, Hein, and Roobol, Monique J.

Published
2024
Full Text
View/download PDF

5. Sex-stratified mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophrenia

Author

Solmi, Marco, Croatto, Giovanni, Fabiano, Nicholas, Wong, Stanley, Gupta, Arnav, Fornaro, Michele, Schneider, Lynne Kolton, Rohani-Montez, S. Christy, Fairley, Leanne, Smith, Nathalie, Bitter, István, Gorwood, Philip, Taipale, Heidi, Tiihonen, Jari, Cortese, Samuele, Dragioti, Elena, Rietz, Ebba Du, Nielsen, Rene Ernst, Firth, Joseph, Fusar-Poli, Paolo, Hartman, Catharina, Holt, Richard I G, Høye, Anne, Koyanagi, Ai, Larsson, Henrik, Lehto, Kelli, Lindgren, Peter, Manchia, Mirko, Nordentoft, Merete, Skonieczna-Żydecka, Karolina, Stubbs, Brendon, Vancampfort, Davy, Vieta, Eduard, De Prisco, Michele, Boyer, Laurent, Højlund, Mikkel, and Correll, Christoph U.

Published
2025
Full Text
View/download PDF

6. Cost-effectiveness of PCSK9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden

Author

Landmesser, Ulf, Lindgren, Peter, Hagström, Emil, van Hout, Ben, Villa, Guillermo, Pemberton-Ross, Peter, Arellano, Jorge, Svensson, Maria Eriksson, Sibartie, Mahendra, and Fonarow, Gregg C

Subjects
Clinical Research, Cost Effectiveness Research, Patient Safety, Heart Disease - Coronary Heart Disease, Comparative Effectiveness Research, Heart Disease, Cardiovascular, Good Health and Well Being, Antibodies, Monoclonal, Humanized, Anticholesteremic Agents, Cost-Benefit Analysis, Humans, Myocardial Infarction, Subtilisins, Sweden, Cost-effectiveness, Evolocumab, Low-density lipoprotein cholesterol, Myocardial infarction, PCSK9 inhibitors, Statins
Abstract

AimsTo assess the cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab added to standard-of-care lipid-lowering treatment [maximum tolerated dose (MTD) of statin and ezetimibe] in Swedish patients with a history of myocardial infarction (MI).Methods and resultsCost-effectiveness was evaluated using a Markov model based on Swedish observational data on cardiovascular event rates and efficacy from the FOURIER trial. Three risk profiles were considered: recent MI in the previous year; history of MI with a risk factor; and history of MI with a second event within 2 years. For each population, three minimum baseline low-density lipoprotein cholesterol (LDL-C) levels were considered: 2.5 mmol/L (≈100 mg/dL), based on the current reimbursement recommendation in Sweden; 1.8 mmol/L (≈70 mg/dL), based on 2016 ESC/EAS guidelines; and 1.4 mmol/L (≈55 mg/dL), or 1.0 mmol/L (≈40 mg/dL) for MI with a second event, based on 2019 ESC/EAS guidelines. Proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab was associated with increased quality-adjusted life-years and costs vs. standard-of-care therapy. Incremental cost-effectiveness ratios (ICERs) were below SEK700 000 (∼€66 500), the generally accepted willingness-to-pay threshold in Sweden, for minimum LDL-C levels of 2.3 (recent MI), 1.7 (MI with a risk factor), and 1.7 mmol/L (MI with a second event). Sensitivity analyses demonstrated that base-case results were robust to changes in model parameters.ConclusionProprotein convertase subtilisin/kexin type 9 inhibition with evolocumab added to MTD of statin and ezetimibe may be considered cost-effective at its list price for minimum LDL-C levels of 1.7-2.3 mmol/L, depending on risk profile, with ICERs below the accepted willingness-to-pay threshold in Sweden.

Published
2022

7. Regional differences in mortality risk and in attenuating or aggravating factors in schizophrenia: A systematic review and meta-analysis

Author

Solmi, Marco, Croatto, Giovanni, Fornaro, Michele, Schneider, Lynne Kolton, Rohani-Montez, S. Christy, Fairley, Leanne, Smith, Nathalie, Bitter, István, Gorwood, Philip, Taipale, Heidi, Tiihonen, Jari, Cortese, Samuele, Dragioti, Elena, Rietz, Ebba Du, Nielsen, Rene Ernst, Firth, Joseph, Fusar-Poli, Paolo, Hartman, Catharina, Holt, Richard I G, Høye, Anne, Koyanagi, Ai, Larsson, Henrik, Lehto, Kelli, Lindgren, Peter, Manchia, Mirko, Nordentoft, Merete, Skonieczna-Żydecka, Karolina, Stubbs, Brendon, Vancampfort, Davy, Boyer, Laurent, De Prisco, Michele, Vieta, Eduard, and Correll, Christoph U.

Published
2024
Full Text
View/download PDF

8. Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensus

Author

Nassr, Ahmed A., Baschat, Ahmet, Hohnecker, Alexander, Shamshirsaz, Alireza, Luciano, Angel, Debeer, Anne, Geipel, Annegret, Borrell, Antoni, Khalil, Asma, Llorente, Aurora Viejo, Mayer, Beate, Poljak, Borna, van der Schoot, C. Ellen, Taillefer, Catherine, Dame, Christof, Berg, Christoph, Coutinho, Conrado Milani, de Winter, Derek P., Oepkes, Dick, Verweij, E.J.T., Moratonas, Elena Carreras, Tiblad, Eleonor, Bendel-Stenzel, Ellen, Maisonneuve, Emeline, Lopriore, Enrico, Vlachodimitropoulou, Evangelia, Prefumo, Federico, Maia, Fernando, Filho, Peixoto, Molina, Francisca S., Gonzalez, Gerardo Sepulveda, Gardener, Glenn, Sago, Haruhiko, Liley, Helen, Mustafa, Hiba, Schwach, Ingrid, Bedei, Ivonne, Castleman, James, Krivec, Jana Lozar, jouannic, Jean-marie, Miller, Jena, Pereira Nunes, Joana Filipa, Middeldorp, Johanna, Martinez, Josep M., Sundberg, Karin, Bligard, Katherine, Kohari, Katherine, Ishii, Keisuke, Moise, Kenneth, Le Duc, Kévin, Lewi, Liesbeth, Van Wyk, Lizelle, Otaño, Lucas, Sun, Luming, Geerts, Lut, Sanchez-Duran, M. Angeles, Bennasar, Mar, Vaena, Marcella, Gil, Maria M., Weems, Mark F., Kilby, Mark, de Haas, Masja, Saxonhouse, Matthew, Schenone, Mauro, Bahtiyar, Mert Ozan, Zaretsky, Michael V., Martinez Rodriguez, Miguel Angel, Habli, Mounira, Khalek, Nahla, Frost, Natalie, Griffiths, Pamela, Maurice, Paul, Dar, Pe'er, Lindgren, Peter, Chaveeva, Petya, Klaritsch, Philipp, Radhakrishnan, Prathima, Schuler, Rahel, Chmait, Ramen, Rose, Rebecca, Oever, Renske van 't, Jernman, Riina, Christensen, Robert, Cincotta, Robert, Axt-Fliedner, Roland, Devlieger, Roland, Donepudi, Roopali, Kumar, Sailesh, Verlohren, Stefan, Emery, Stephen P., Sainio, Susanna, Mehra, Suwan, Premru-Srsen, Tanja, Legler, Tobias, Sachs, Ulrich J., Basal, Vandana, Stefanovic, Vedran, Goodnight, William, Blumenfeld, Yair, Mustafa, Hiba J., Sambatur, Enaja V., Shamshirsaz, Alireza A., Johnson, Sonia, Moise, Kenneth J., Jr., Baschat, Ahmet A., (Joanne) Verweij, E.J.T., Javinani, Ali, Kilby, Mark D., and Snowise, Saul

Published
2024
Full Text
View/download PDF

18. Smart House Case

Author

Lindgren, Peter, primary, Bergenholtz, Carsten, additional, and Saghaug, Kristin Falck, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results